Promising Biomaterial Could Improve Bone Regeneration
This article was originally published in the Northwestern University Feinberg School of Medicine News Center.
A Northwestern University research team has developed 3D printable ink that produces a synthetic bone implant that rapidly induces bone regeneration and growth. This hyper-elastic bone material is easily customizable to different shapes and could one day be especially useful in the treatment of bone defects in children.
Bone implantation surgery is never an easy process, but it is particularly painful and complicated for children. With both adults and children, bone is often harvested from elsewhere in the body to replace the missing bone, which can lead to other complications and pain. Metallic implants are sometimes used, but this is not a permanent fix for growing children.
“Adults have more options when it comes to implants,” said Ramille Shah, PhD, an assistant professor of Surgery in the Division of Organ Transplantation at Northwestern University Feinberg School of Medicine and of Materials Science and Engineering at the McCormick School of Engineering. “Pediatric patients do not. If you give them a permanent implant, you have to do more surgeries in the future as they grow. They might face years of difficulty.”
Shah and her team aim to change the nature of bone implants, and they particularly want to help pediatric patients. Adam Jakus, PhD, a postdoctoral fellow in Shah’s laboratory, is the first author of the study, which evaluated the material with human stem cells and within animal models.
Shah’s 3-D printed biomaterial is a mix of hydroxyapatite (a calcium mineral found naturally in human bone) and a biocompatible, biodegradable polymer. The material is majority hydroxyapatite, yet it is hyper-elastic, robust and porous at the nano, micro and macro levels. These unique properties have contributed to the printed structure’s great promise in in vivo animal models.
“Porosity is huge when it comes to tissue regeneration, because you want cells and blood vessels to infiltrate the scaffold,” Shah said. “Our 3-D structure has different levels of porosity that work to the advantage of its physical and biological properties.”
While hydroxyapatite has been proven to induce bone regeneration, it is also notoriously tricky to work with. Clinical products that use hydroxyapatite or other calcium phosphate ceramics are hard and brittle. To compensate for that, previous researchers created structures composed mostly of polymers, but this shields the activity of the bioceramic. Shah’s bone biomaterial, however, is 90 percent by weight hydroxyapatite and just 10 percent by weight polymer, and it still maintains its elasticity because of the way its structure is designed and printed. The high concentration of hydroxyapatite creates an environment that induces rapid bone regeneration.
“Cells can sense the hydroxyapatite and respond to its bioactivity,” Shah said. “When you put stem cells on our scaffolds, they turn into bone cells and start to up-regulate their expression of bone-specific genes. This is in the absence of any other osteo-inducing substances. It’s just the interaction between the cells and the material itself.”
That’s not to say that other substances couldn’t be combined into the ink. Because the 3-D printing process is performed at room temperature, Shah’s team was able to incorporate other elements, such as antibiotics, into the ink.
“We can incorporate antibiotics to reduce the possibility of infection after surgery,” Shah said. “We also can combine the ink with different types of growth factors, if needed, to further enhance regeneration. It’s really a multi-functional material.”
One of the biggest advantages, however, is that the end product can be customized to the patient. In traditional bone transplant surgeries, the bone — after it’s taken from another part of the body — has to be shaped and molded to exactly fit the area where it is needed. Using Shah’s synthetic material, physicians would be able to scan the patient’s body and 3-D print a personalized product. Alternatively, due to its mechanical properties, the biomaterial also can be easily trimmed and cut to size and shape during a procedure. Not only is this faster, but also less painful compared to using autograft material.
Shah imagines that hospitals may one day have 3-D printers, where customized implants can be printed while the patient waits.
“The turnaround time for an implant that’s specialized for a customer could be within 24 hours,” Shah said. “That could change the world of craniofacial and orthopaedic surgery, and, I hope, will improve patient outcomes.”